However, previous studies have reported conflicting results regarding changes in Lp-PLA2 concentrations in MASLD, and it remains unclear whether Lp-PLA2 activity, which more accurately reflects its biological role, is affected by MASLD status [10,11]. The gene discussed is PLA2G7; the disease is metabolic dysfunction-associated steatotic liver disease.